Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
INKT MiNK Therapeutics
- 0.960
- +0.010+1.07%
Trading Jan 22 11:39 ET
37.98MMarket Cap-2.60P/E (TTM)
0.975High0.870Low140.82KVolume0.901Open0.950Pre Close128.19KTurnover1.39%Turnover RatioLossP/E (Static)39.55MShares1.90052wk High-2.16P/B9.75MFloat Cap0.46352wk Low--Dividend TTM10.16MShs Float22.155Historical High--Div YieldTTM11.04%Amplitude0.463Historical Low0.910Avg Price1Lot Size
About MiNK Therapeutics Company
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
Company Profile
SymbolINKT
Company NameMiNK Therapeutics
Listing DateOct 15, 2021
Issue Price12.00
Founded2017
CEODr. Jennifer S. Buell, PhD
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address149 5th Avenue,Suite 500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-994-8250
Company Executives
- Name
- Position
- Salary
- Dr. Jennifer S. Buell, PhD
- President, Chief Executive Officer and Director
- 2.81M
- Christine M. Klaskin
- Treasurer, Principal Financial Officer and Principal Accounting Officer
- 29.62K
- Dr. Garo H. Armen, PhD
- Chairman of the Board
- 344.32K
- Dr. Robert Kadlec
- Director
- --
- Barbara Ryan
- Independent Director
- 154.25K
- Peter Behner
- Independent Director
- 111.45K
- Ulf Wiinberg
- Independent Director
- 106.95K
- Brian J. Corvese
- Independent Director
- 154.75K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart